Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 278.82 | N/A |
| PEG Ratio (TTM) | 1.34 | N/A |
| P/S Ratio (TTM) | 4.12 | N/A |
| P/B Ratio (TTM) | 12.05 | N/A |
| P/FCF Ratio (TTM) | 104.75 | N/A |
| Price to 5YR AVG Earnings Ratio | -18.07 | N/A |
| Price to 5YR AVG FCF Ratio | -32.04 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.63% | N/A |
| ROE (TTM) | 4.85% | N/A |
| Net Profit Margin (TTM) | 1.47% | N/A |
| ROIC 5YR AVG | -336.78% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3,031.33% | 9.54% | 28.40% |
| Revenue | 17.36% | 29.51% | 22.27% |
| Net Income | 3,074.32% | 2.85% | 23.57% |
| Cash Flow | 306.33% | -25.86% | 21.42% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.95 | N/A |
| Quick Ratio (TTM) | 2.35 | N/A |
| D/E Ratio (TTM) | 0.03 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 9.25 | N/A |
| LTL to 5YR AVG FCF | -0.20 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.42% | N/A |